J&J's OTC sales rise at home but fall abroad

18 July 2017 - Deborah Wilkes


Worldwide OTC sales at Johnson & Johnson increased by 2.1% on an operational basis in the second quarter of 2017, thanks to a rise of 6.7% in the US.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: